Spanish pharmaceutical company Rovi said on Thursday it had hired financial advisory and asset management firm Lazard to explore the sale of its third-party manufacturing business that it uses to make COVID vaccines. Madrid-based Rovi said it regularly assesses potential strategic alternatives to maximise value and decided to hire Lazard, although no specific decision had been taken and the analysis was still ongoing.